Overall assessment
The telehealth section now follows the agreed strategy and contains the required factual corrections. However, I would not approve the full article yet.
The main remaining problems are in the original pharmacy sections: unsupported claims, overly absolute language, regulatory overreach, and several FitXpress capability descriptions that go beyond the confirmed product position.
Required changes
0. Follow the General Approach & Language Guardrails for Corporate Content - 3DLOOK 
https://docs.google.com/document/d/1dPNXQL62t_y82MFJblBidEvRgwXjJxzADdapB7Pa214/edit?tab=t.0#heading=h.jobkgwp08yw5 
For example: “Plus” - should be avoided 
1. Substantiate or soften the opening claims
These statements are presented as established industry facts without supporting evidence:
“Online pharmacy clinical teams across the UK have been having the same conversation for months.”
“Patients are using free AI tools to alter photos…”
“Pharmacists are flagging this as a recurring clinical risk…”
“The pharmacists raising it are working from documented submission behaviour…”
Either provide a published source or clearly attribute the information to 3DLOOK’s customer conversations.
Recommended direction:
In conversations with UK online pharmacy teams, 3DLOOK has heard growing concerns about patients using generative AI tools to alter body photos submitted during weight-loss medication assessments.
Remove “documented submission behaviour” unless documentation can be cited.
2. Reduce absolute and adversarial language
The following formulations are too categorical:
* “Photo upload has stopped working”
* “No longer satisfies the evidentiary standard”
* “Trusting that the content tells the truth”
* “The manipulation door”
* “Attacker”
* “Inflation attempt”
* “What is verifiably real”
The article should identify the limitations of camera-roll uploads without implying that every upload is unreliable or every patient is attempting fraud.
Suggested heading:
Why camera-roll uploads provide limited verification
Suggested central formulation:
A camera-roll image can support visual review, but it provides limited evidence about when, how, or by whom the image was created.
3. Remove the Munich Re evidence
The Munich Re material concerns insurance underwriting, rather than online pharmacy prescribing. It does not establish the prevalence or nature of misreporting in pharmacy workflows.
Remove:
“BMI is the second-largest driver of misrepresentation…”
“misrepresentation rates of 20% or higher…”
It introduces an adjacent industry and makes the argument look assembled from indirect evidence.
4. Remove the KFF paragraph
The KFF statistics are accurate, but they concern US employer health-plan coverage. They do not demonstrate growing UK pharmacy order volume or establish that BMI is the eligibility trigger for all covered patients. KFF’s survey reports coverage and program conditions, rather than pharmacy verification practices.
Remove the entire paragraph. It adds length without supporting the article’s central claim.
5. Reframe Katerina’s AI experiment
The experiment illustrates technical possibility. It does not demonstrate prevalence, successful pharmacy deception, or what would pass clinical review.
Remove or revise:
“the easiest variant for an attacker”
“believable enough to pass at a quick clinical glance”
Use:
The experiment demonstrated how quickly generative AI tools can produce plausible altered body images. It did not test whether those images would pass a pharmacy’s clinical review.
6. Remove the FDA enforcement example
The FDA letters concern false or misleading promotion of compounded GLP-1 products by telehealth companies. They do not concern remote BMI verification or patient-submitted evidence. The FDA’s March 2026 announcement therefore cannot support this conclusion:
“Regulators in both major markets have started to move from posture to enforcement.”
Keep the GPhC requirement only. The February 2025 guidance directly requires independent verification of weight, height and/or BMI for weight-management medicines. GPhC guidance
7. Do not present the feature list as a regulatory “minimum standard”
The GPhC requires independent verification, but it does not establish live SDK capture, liveness, clothing detection, AI-derived weight, or exportable logs as the regulatory minimum.
Change:
“The minimum standard for online pharmacy BMI verification in 2026”
To:
Capabilities to evaluate in a remote BMI verification workflow
Also change:
“the floor a serious eligibility gate has to clear”
To:
“a set of capabilities pharmacies can evaluate according to their clinical and governance requirements.”
8. Separate liveness from identity verification
Liveness can indicate that a live person completed the capture. It does not necessarily prove that the person is the named patient.
Revise:
“can be traced back to the person who created it”
And:
“a real person is on camera”
To:
Liveness checks can help confirm that the capture was completed live rather than reproduced from a static image or prerecorded source. Patient identity verification may require a separate control.
Also retain “a printed photo or screen does not pass” only if this exact behavior has been validated.
9. Correct the clothing-detector claims
The detector can classify or flag clothing fit/bulkiness. It cannot determine patient intent.
Replace:
“baggy-clothing inflation attempt”
“oversized attire used to inflate visual BMI”
With:
The clothing detector flags clothing that may reduce the reliability of the scan, allowing the workflow to request a retake or route the session for review.
10. Correct the Smart Scales description
“Smart Scales” is the predicted-weight output, not the cross-check itself.
Replace:
“Smart Scales cross-checks the patient’s self-reported weight…”
With:
FitXpress can generate a predicted-weight estimate through its Smart Scales capability. Where the workflow also collects self-reported weight, the customer can compare the two values and apply its own mismatch threshold and review protocol.
11. Qualify the audit-record claims
The article still attributes a complete “audit-ready evidence trail” to FitXpress. This conflicts with the corrected telehealth section, which properly assigns review and decision records to the customer.
Revise the use-case summary:
Outputs: Predicted weight, BMI calculated using supplied height, 80+ body measurements, body-composition estimates, and structured session and validation data
Role: Server-side body-data verification step
Business value: Additional evidence for eligibility review and structured data that can support the pharmacy’s documentation workflow
Remove:
* “HIPAA/GDPR-compliant audit trail”
* “audit-ready evidence collection”
* Guaranteed regulator acceptance
* Exportable logs, unless that functionality is confirmed for the deployment
12. Correct the privacy paragraph
This sequence is confusing:
“Production photos are deleted after processing by default…”
“Any stored images are automatically blurred.”
Clarify what happens during processing:
Images are blurred as part of the privacy-protection workflow and deleted after processing by default. Structured outputs are retained according to the customer’s configuration and contractual terms.
Also use:
FitXpress is HIPAA compliant, with a Business Associate Agreement available on request, and supports GDPR-aligned deployments.
Avoid calling an audit trail itself “HIPAA/GDPR compliant.”
13. Remove the HHS breach statistic
The 2023 breach statistic is too far removed from BMI verification and interrupts the product explanation. General healthcare breach volume does not prove the security of FitXpress architecture.
Remove the complete sentence beginning:
“That posture matters in a context where the HHS Office for Civil Rights reported…”
Link directly to the security or technology page instead.
14. Strengthen or remove the anonymous customer proof
“A leading UK online pharmacy is the live reference.”
This is too vague to function as credible evidence.
Either provide:
* The customer name
* A linked case study
* An approved operational metric
* A clearly qualified anonymous example
Otherwise use:
FitXpress is currently deployed in a UK online pharmacy order flow.
Remove:
“They are the proof that the pattern works…”
unless production-scale evidence is published.
15. Remove overclaims from the vendor checklist
Revise:
“Only the second produces a verification signal a regulator will recognise.”
To:
Liveness provides a different verification signal from image-quality validation and can support the pharmacy’s wider verification controls.
Also revise:
“A scan-derived estimate that matches the self-report is reassuring evidence…”
To:
The program should define acceptable differences and exception-routing thresholds according to its protocol, taking the expected error range of the estimate into account.
And replace:
“If a vendor cannot answer the first two cleanly, the rest does not matter.”
With:
In-session capture and liveness should be evaluated alongside accuracy, privacy, integration, documentation, and clinical workflow requirements.
16. Remove the repeated CDC paragraph from the telehealth section
The same 40% CDC finding appears twice in one article. Keep it in the telehealth section, where it is accurately qualified, and shorten the earlier discussion.
The CDC finding concerns population-level prevalence of severe obesity—not individual submission accuracy. The revised telehealth wording handles that limitation correctly. CDC study
17. Shorten the telehealth addition
The section is accurate but has grown beyond the recommended 500–800 words and repeats:
* Privacy and retention
* FitXpress inputs and outputs
* The CDC evidence
* Review responsibilities
* Product boundaries
Keep:
1. When additional verification may be needed
2. Four available methods
3. The five-step practical workflow
4. One concise FitXpress subsection
The final paragraph covering HIPAA, GDPR, retention, DXA and BIA can be shortened because these points already appear elsewhere in the article.
18. Adjust the final CTA
The conclusion returns to absolute language:
“That is what FitXpress does…”
“audit-ready evidence collection”
Use:
FitXpress replaces camera-roll uploads with guided live capture and provides predicted weight, calculated BMI, body measurements, and structured validation data that pharmacies can integrate into their eligibility-review and documentation workflows.
Final verdict
The decision to integrate telehealth BMI verification into the existing article has been implemented correctly, and the new section is substantially stronger than the original standalone draft.
The article still needs a meaningful revision before approval, mainly to:
* Remove indirect and irrelevant supporting evidence
* Distinguish recommended capabilities from regulatory requirements
* Eliminate intent-based fraud claims
* Correct the Smart Scales, liveness, clothing, and audit-trail descriptions
* Reduce repeated and overly forceful language
After those changes, it should become a strong canonical BOFU guide covering both pharmacy order-flow verification and the related telehealth workflow.